NCT03370380View on ClinicalTrials.gov

Aflibercept in Patients With Pigment Epithelial Detachments (PED)

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

April 17, 2015

Primary Completion Date

April 23, 2018

Study Completion Date

April 23, 2018

Conditions
Pigment Epithelial Detachment
Interventions
DRUG

Aflibercept

Patients are treated according to authorization of Aflibercept

Trial Locations (1)

48149

University Hospital Muenster, Münster

All Listed Sponsors
lead

University Hospital Muenster

OTHER

NCT03370380 - Aflibercept in Patients With Pigment Epithelial Detachments (PED) | Biotech Hunter | Biotech Hunter